Form D Raw Data - Electronic Filing Depository

EFDID: 335046EFD: Raw Data

Issuer: Aspargo Laboratories, Inc. (0001805092) - D

Accession: 0001753926-20-000030 () (EDGAR Files) (Form D)

Edgar Posted: Mar. 3, 2020
EFD Posted: Mar. 3, 2020

- < edgarSubmission >

< schemaVersion > X0708 </ schemaVersion >

< submissionType > D </ submissionType >

< testOrLive > LIVE </ testOrLive >

- < primaryIssuer >

< cik > 0001805092 </ cik >

< entityName > Aspargo Laboratories, Inc. </ entityName >

- < issuerAddress >

< street1 > 550 SYLVAN AVENUE, SUITE 102 </ street1 >

< city > ENGLEWOOD CLIFFS </ city >

< stateOrCountry > NJ </ stateOrCountry >

< stateOrCountryDescription > NEW JERSEY </ stateOrCountryDescription >

< zipCode > 07632 </ zipCode >

</ issuerAddress >

< issuerPhoneNumber > 201-408-4831 </ issuerPhoneNumber >

< jurisdictionOfInc > DELAWARE </ jurisdictionOfInc >

- < issuerPreviousNameList >

< previousName > VirgaTech, Inc. </ previousName >

</ issuerPreviousNameList >

- < edgarPreviousNameList >

< value > None </ value >

</ edgarPreviousNameList >

< entityType > Corporation </ entityType >

- < yearOfInc >

< withinFiveYears > true </ withinFiveYears >

< value > 2019 </ value >

</ yearOfInc >

</ primaryIssuer >

- < relatedPersonsList >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Michael </ firstName >

< lastName > Demurjian </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 610 Hubbard Avenue </ street1 >

< city > Red Bank </ city >

< stateOrCountry > NJ </ stateOrCountry >

< stateOrCountryDescription > NEW JERSEY </ stateOrCountryDescription >

< zipCode > 07701 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Executive Officer </ relationship >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Michael </ firstName >

< lastName > Rice </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 155 Walnut St. </ street1 >

< city > Englewood </ city >

< stateOrCountry > NJ </ stateOrCountry >

< stateOrCountryDescription > NEW JERSEY </ stateOrCountryDescription >

< zipCode > 07631 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

- < relatedPersonInfo >

- < relatedPersonName >

< firstName > Fred </ firstName >

< lastName > Biehl </ lastName >

</ relatedPersonName >

- < relatedPersonAddress >

< street1 > 75 Eisenhower Parkway </ street1 >

< city > Roseland </ city >

< stateOrCountry > NJ </ stateOrCountry >

< stateOrCountryDescription > NEW JERSEY </ stateOrCountryDescription >

< zipCode > 07068 </ zipCode >

</ relatedPersonAddress >

- < relatedPersonRelationshipList >

< relationship > Director </ relationship >

</ relatedPersonRelationshipList >

</ relatedPersonInfo >

</ relatedPersonsList >

- < offeringData >

- < industryGroup >

< industryGroupType > Pharmaceuticals </ industryGroupType >

</ industryGroup >

- < issuerSize >

< revenueRange > No Revenues </ revenueRange >

</ issuerSize >

- < federalExemptionsExclusions >

< item > 06b </ item >

</ federalExemptionsExclusions >

- < typeOfFiling >

- < newOrAmendment >

< isAmendment > false </ isAmendment >

</ newOrAmendment >

- < dateOfFirstSale >

< value > 2020-02-05 </ value >

</ dateOfFirstSale >

</ typeOfFiling >

- < durationOfOffering >

< moreThanOneYear > false </ moreThanOneYear >

</ durationOfOffering >

- < typesOfSecuritiesOffered >

< isEquityType > true </ isEquityType >

</ typesOfSecuritiesOffered >

- < businessCombinationTransaction >

< isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >

</ businessCombinationTransaction >

< minimumInvestmentAccepted > 10000 </ minimumInvestmentAccepted >

< salesCompensationList />

- < offeringSalesAmounts >

< totalOfferingAmount > 8500000 </ totalOfferingAmount >

< totalAmountSold > 235000 </ totalAmountSold >

< totalRemaining > 8265000 </ totalRemaining >

</ offeringSalesAmounts >

- < investors >

< hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >

< totalNumberAlreadyInvested > 6 </ totalNumberAlreadyInvested >

</ investors >

- < salesCommissionsFindersFees >

- < salesCommissions >

< dollarAmount > 0 </ dollarAmount >

</ salesCommissions >

- < findersFees >

< dollarAmount > 0 </ dollarAmount >

</ findersFees >

< clarificationOfResponse />

</ salesCommissionsFindersFees >

- < useOfProceeds >

- < grossProceedsUsed >

< dollarAmount > 0 </ dollarAmount >

</ grossProceedsUsed >

< clarificationOfResponse > The company is virtual. All executives are acting as consultants without cash compensation. </ clarificationOfResponse >

</ useOfProceeds >

- < signatureBlock >

< authorizedRepresentative > false </ authorizedRepresentative >

- < signature >

< issuerName > Aspargo Laboratories, Inc. </ issuerName >

< signatureName > /s/ Michael Demurjian </ signatureName >

< nameOfSigner > Michael Demurjian </ nameOfSigner >

< signatureTitle > CEO </ signatureTitle >

< signatureDate > 2020-03-03 </ signatureDate >

</ signature >

</ signatureBlock >

</ offeringData >

</ edgarSubmission >